SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001309014-13-000519
Filing Date
2013-07-25
Accepted
2013-07-25 10:17:02
Documents
4
Period of Report
2013-07-25

Document Format Files

Seq Description Document Type Size
1 LIVE FILING htm_7864.htm 6-K 9676
2 EX-99.1 exhibit1.htm EX-99.1 15521
3 GRAPHIC e6850-1320610141038133518_1.jpg GRAPHIC 3498
4 GRAPHIC e6850-1320610141038133518_2.jpg GRAPHIC 4289
  Complete submission text file 0001309014-13-000519.txt   37305
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-16174 | Film No.: 13985268
SIC: 2834 Pharmaceutical Preparations